These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 11965829)

  • 1. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
    Groop L
    Int J Clin Pract Suppl; 2000 Oct; (113):3-13. PubMed ID: 11965829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance as the core defect in type 2 diabetes mellitus.
    Goldstein BJ
    Am J Cardiol; 2002 Sep; 90(5A):3G-10G. PubMed ID: 12231073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance: the fundamental trigger of type 2 diabetes.
    Groop LC
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S1-7. PubMed ID: 11220283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Szoke E; Gerich JE
    Compr Ther; 2005; 31(2):106-12. PubMed ID: 15901939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-insulin-dependent diabetes mellitus--a collision between thrifty genes and an affluent society.
    Groop LC; Tuomi T
    Ann Med; 1997 Feb; 29(1):37-53. PubMed ID: 9073323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From obesity to type 2 diabetes.
    Scheen AJ
    Acta Clin Belg Suppl; 1992; 14():30-6. PubMed ID: 1604959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the pathogenesis of type 2 diabetes: can we get off the metabolic merry-go-rounds?
    Proietto J; Andrikopoulos S; Rosella G; Thorburn A
    Aust N Z J Med; 1995 Dec; 25(6):870-5. PubMed ID: 8770366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is insulin resistance the principal cause of type 2 diabetes?
    Gerich JE
    Diabetes Obes Metab; 1999 Sep; 1(5):257-63. PubMed ID: 11225637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.
    Pratley RE; Weyer C
    Diabetologia; 2001 Aug; 44(8):929-45. PubMed ID: 11484070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathophysiology of type 2 diabetes mellitus: an overview.
    Ostenson CG
    Acta Physiol Scand; 2001 Mar; 171(3):241-7. PubMed ID: 11412136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiological basis of insulin secretion abnormalities].
    Pinget M; Boullu-Sanchis S
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S21-32. PubMed ID: 12703062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and insulin sensitizers.
    Stumvoll M; Häring H
    Horm Res; 2001; 55 Suppl 2():3-13. PubMed ID: 11684868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (part II)].
    Martinka E; Galajda P; Mokán M
    Vnitr Lek; 1996 Mar; 42(3):200-4. PubMed ID: 8686211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management.
    Roseman HM
    J Manag Care Pharm; 2005 Aug; 11(6 Suppl B):S3-11. PubMed ID: 23570224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucotoxicity and lipotoxicity: factors in the pathogenesis and evolution of type 2 diabetes].
    Durruty P; García de los Ríos M
    Rev Med Chil; 2001 Jun; 129(6):671-9. PubMed ID: 11510210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.